Amélie Laurendon is a protein biochemist with over 15 years of experience in the biopharmaceutical industry, specializing in the engineering, production, and characterization of large-molecule for drug discovery. She earned a Master's degree in Biotechnology from ENSTBB, a French engineering school specializing in biotechnology. Amélie currently leads the Developability Science team in Discovery at IGI (Ichnos Glenmark Innovation) and holds the position of Associate Research Fellow within the Antibody Discovery and Engineering Department.